Mannkind Corporation(MNKD)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

MNKD $4.13
Snapshot
$4.13
After hours $4.15 +0.48%
52-Week Range
$2.23 – $6.51
YTD
-26.25%
IV Rank (30D)
35.01
Straddle Price
$0.97
P/C Vol Ratio
0.11
Market Cap
$1.2B
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.63%
Beta vs SPY1.00
Cost of Equity (CAPM)10.13% (VRP-adj)
WACC8.61%
Volatility Risk Premium+187.1pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+17.8%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.10 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$0.0B
Return on Equity (TTM)40.4%
Book / Price-4.9%
Gross Margin (TTM)75.6%
FCF Margin (TTM)3.6%
Quality Score3/6 — normal (10y DCF)
SMA 50$3.76 (Market Anchor value)
SMA 20 / Bollinger Mid$4.10
Bollinger Width / SMA20379.5% (drives anchor stability)
Net Debt$0.4B
Market Cap$1B
Peers used for multiples: ABBV, AMGN, EW, JNJ, KYMR, LLY, MRK, REGN
Model Conviction
67%
20-Day Fair Value
≈ by Aug 24, 2026
$4.61
α +11.7% rank 32%
40-Day Fair Value
≈ by Sep 22, 2026
$4.17
α +1.0% rank 46%
60-Day Fair Value
≈ by Oct 21, 2026
$4.50
α +9.0% rank 53%
MethodImplied PriceWeightDetail
DCF $0.38 40%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 35.2× · 7 peers
Peer EV/EBITDA $0.97 36% median 18.7× · 7 peers
Peer P/B n/a 0% median 6.9× · 7 peers
Peer P/S $8.61 24% median 6.8× · 8 peers
Market Anchor (SMA50) $3.76 0% stability 0% (BB-width)
Options Expected (B-L 30d) $2.81 0% 7 strikes · skew +1.34
As of 2026-07-24 · updated
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$1.2B

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, wh…

Summary
composite
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan +2.68% 22
Feb -3.20% 22
Mar -2.16% 22
Apr -5.33% 22
May +10.96% 22
Jun +4.44% 22
Jul -5.79% 23
Aug +1.04% 22
Sep +3.96% 22
Oct -4.06% 22
Nov +2.03% 22
Dec -1.83% 22
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $4.11
SMA 50: $3.77
SMA 200: $4.37
Current: $4.09
EMA 12: $4.02
EMA 26: $3.97
MACD: 0.0449 | Signal: -0.0414
BULLISH
ADX (14): 28.16
TREND
+DI: 26.59
−DI: 17.90
Momentum Oscillators
RSI (14): 54.47
NEUTRAL
Stoch %K: 27.15
Stoch %D: 20.89
Williams %R: -44.67
Volume & Volatility
BB Upper: $4.42
BB Lower: $3.80
NEUTRAL
OBV: -61,105,638
Vol SMA 20: 5,035,860
Vol ROC: 98.39%
ATR: $0.23
True Range: $0.34
HV 20: 60.6%
HV 30: 58.6%
HV 60: 71.1%

Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-07-25T00:00:00 – 2026-07-23T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
7 of 8 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-07 After-Close 7.07% 4.24% 0.60x Within
2024-11-07 After-Close 8.68% 1.94% 0.22x Within
2025-02-26 After-Close 10.59% 10.85% 1.02x Exceeded
2025-05-08 Pre-Market 9.80% 4.44% 0.45x Within
2025-08-06 After-Close 8.50% 2.83% 0.33x Within
2025-11-05 After-Close 6.60% 5.94% 0.90x Within
2026-02-26 Pre-Market 16.43% 7.29% 0.44x Within
2026-05-06 After-Close 6.20% 2.48% 0.40x Within
Options Activity
IV Rank (30D)
35.01
IV Rank (7D)
87.28
Avg IV
185.7%
Straddle (30D)
$0.97
Straddle (7D)
$0.65
P/C Volume
0.11
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
pts EXTREME
ATM — / Wing —
30 DTE / 10d
pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.96
Correlation (SPY)
16.6%
0.03
Ann. Volatility
73.5%
SPY Volatility
12.7%

Moderate volatility - stock generally follows market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-06-30
Diluted shares outstanding: 311,375,250 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

250 filers177,460,667 shares$516.16M value56.99% of float
# Filer Shares Value % of Total % of Float Period
1 VANGUARD GROUP INC Custodian 17,880,873 $101.38M 19.64% 5.74% 2025-12-31
2 BlackRock, Inc. Custodian 28,600,998 $70.07M 13.58% 9.19% 2026-03-31
3 STATE STREET CORP 18,683,483 $45.77M 8.87% 6.00% 2026-03-31
4 MORGAN STANLEY Custodian 4,443,922 $25.20M 4.88% 1.43% 2025-12-31
5 180 WEALTH ADVISORS, LLC 4,959,351 $21.13M 4.09% 1.59% 2026-06-30
6 UBS Group AG Custodian 8,255,430 $20.23M 3.92% 2.65% 2026-03-31
7 GEODE CAPITAL MANAGEMENT, LLC Custodian 7,505,147 $18.39M 3.56% 2.41% 2026-03-31
8 MILLENNIUM MANAGEMENT LLC Custodian 6,390,922 $15.66M 3.03% 2.05% 2026-03-31
9 Frazier Life Sciences Management, L.P. 5,900,000 $14.46M 2.80% 1.89% 2026-03-31
10 DIMENSIONAL FUND ADVISORS LP Custodian 4,953,295 $12.13M 2.35% 1.59% 2026-03-31
11 Rubric Capital Management LP 3,620,413 $8.87M 1.72% 1.16% 2026-03-31
12 FMR LLC Custodian 3,480,964 $8.53M 1.65% 1.12% 2026-03-31
13 BANK OF AMERICA CORP /DE/ Custodian 3,383,677 $8.29M 1.61% 1.09% 2026-03-31
14 TSP Capital Management Group, LLC 3,343,975 $8.19M 1.59% 1.07% 2026-03-31
15 WELLINGTON MANAGEMENT GROUP LLP Custodian 3,283,179 $8.04M 1.56% 1.05% 2026-03-31
16 GOLDMAN SACHS GROUP INC Custodian 2,942,320 $7.21M 1.40% 0.94% 2026-03-31
17 TWO SIGMA INVESTMENTS, LP 2,895,874 $7.09M 1.37% 0.93% 2026-03-31
18 NORTHERN TRUST CORP Custodian 2,675,950 $6.56M 1.27% 0.86% 2026-03-31
19 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2,549,067 $6.25M 1.21% 0.82% 2026-03-31
20 Avoro Capital Advisors LLC 2,200,000 $5.39M 1.04% 0.71% 2026-03-31
21 Nuveen, LLC Custodian 2,164,715 $5.30M 1.03% 0.70% 2026-03-31
22 Qube Research & Technologies Ltd 2,149,393 $5.27M 1.02% 0.69% 2026-03-31
23 RENAISSANCE TECHNOLOGIES LLC 1,868,442 $4.58M 0.89% 0.60% 2026-03-31
24 MARSHALL WACE, LLP Custodian 1,561,889 $3.83M 0.74% 0.50% 2026-03-31
25 Point72 Asset Management, L.P. 1,249,177 $3.06M 0.59% 0.40% 2026-03-31
5 filers$3.03M notional
# Filer Notional Value % of Total Period
1 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $1.25M 41.31% 2026-03-31
2 Stonepine Capital Management, LLC $1.23M 40.44% 2026-03-31
3 CITADEL ADVISORS LLC Custodian $312.13K 10.31% 2026-03-31
4 JANE STREET GROUP, LLC Custodian $238.38K 7.87% 2026-03-31
5 180 WEALTH ADVISORS, LLC $2.13K 0.07% 2026-06-30
4 filers$4.64M notional
# Filer Notional Value % of Total Period
1 Caption Management, LLC $2.45M 52.85% 2026-03-31
2 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $1.27M 27.31% 2026-03-31
3 CITADEL ADVISORS LLC Custodian $755.09K 16.29% 2026-03-31
4 JANE STREET GROUP, LLC Custodian $165.13K 3.56% 2026-03-31
Insider Activity
Latest: 2026-07-17
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-07-17 Dominic Marasco Pres, Endocrine Business Unit Tax (F) −3,623 $4.09 -$14.8K EDGAR
2026-07-17 Sanjay R Singh EVP Technical Operations Mixed +23,755 $4.09 -$191.4K EDGAR
2026-07-17 Michael Castagna Chief Executive Officer Mixed −12,940 $4.09 -$1.49M EDGAR
2026-07-17 Christopher B Prentiss Chief Financial Officer Tax (F) −22,247 $4.09 -$91.0K EDGAR
2026-07-17 Stuart A Tross Chief People & Workpl Officer Mixed +27,982 $4.09 -$269.2K EDGAR
2026-07-17 Steven B. Binder Director Mixed +16,910 $4.07 -$312.9K EDGAR
2026-07-17 David Thomson EVP Genl Counsel & Secretary Mixed −28,745 $4.08 -$500.2K EDGAR
2026-05-22 Stuart A Tross Chief People & Workpl Officer Award (A) +33,898 $2.95 $100.0K EDGAR
2026-05-22 ANTHONY C HOOPER Director Grant (A) +99,337 RSU EDGAR
2026-05-22 Michael A Friedman Director Grant (A) +82,781 RSU EDGAR
2026-05-22 Jennifer Grancio Director Award (A) EDGAR
2026-05-22 Sabrina Kay Director Award (A) EDGAR
2026-05-22 Steven B. Binder Director Grant (A) +82,781 RSU EDGAR
2026-05-22 Ronald J Consiglio Director Award (A) +10,000 $2.95 $29.5K EDGAR
2026-05-22 James Samuel Shannon Director Award (A) EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
39 insiders · @ $4.09
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Michael Castagna Chief Executive Officer 2,605,660 $10.67M -$3.79M 75 2026-07-17
2 Stuart A Tross Chief People & Workpl Officer 1,058,142 $4.33M -$1.38M 57 2026-07-17
3 ALFRED E MANN Executive Chairman 1,007,702 $4.13M $378.97M 31 2015-09-03
4 Steven B. Binder Director 877,403 $3.59M -$2.56M 44 2026-07-17
5 David Thomson EVP Genl Counsel & Secretary 868,457 $3.56M -$6.35M 102 2026-07-17
6 Alejandro Galindo EVP Endocrine Business Unit 781,690 $3.20M $324.9K 17 2022-08-24
7 Joseph Kocinsky Chief Technology Officer 745,233 $3.05M $0 17 2022-08-29
8 KENT KRESA Director 512,130 $2.10M $999.6K 22 2024-05-17
9 Sanjay R Singh EVP Technical Operations 478,966 $1.96M -$94.4K 12 2026-07-17
10 BURKHARD BLANK EVP Chief Medical Officer 460,791 $1.89M $0 7 2025-07-17
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2026-07-17
Last 30d: 2 filings · $309K notice value  ·  Last 90d: 5 filings · $410K notice value · 2 unique filers · 100% under 10b5-1 plans

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: STEVEN BINDER (2, $269K) · DAVID THOMSON (3, $141K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-07-17 DAVID THOMSON Officer 24,109 $97.4K 2026-07-17 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-07-17 STEVEN BINDER Director 52,485 $212.0K 2026-07-17 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-05-14 144/A Thomson David Officer 3,033 $9.9K 2026-05-12 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-05-12 DAVID THOMSON Officer 10,113 $34.0K 2026-05-12 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-05-12 STEVEN BINDER Director 16,940 $56.9K 2026-05-12 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-01-08 STUART A TROSS Officer 47,000 $297.5K 2026-01-08 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2025-12-12 MICHAEL CASTAGNA Director, Officer 107,920 $627.0K 2025-12-12 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2025-12-02 DAVID THOMSON Officer 147,780 $802.4K 2025-12-02 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2025-12-02 MICHAEL CASTAGNA Director, Officer 107,920 $586.0K 2025-12-02 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2025-11-14 SANJAY SINGH Officer 18,777 $94.5K 2025-11-14 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio-20.0
P/S Ratio3.3
EV/EBITDA45.9
TTM Revenue$0.4B
TTM Net Income$-0.0B
TTM EPS$-0.07
ROE40.4%
Debt/Equity-8.22